Hence, CD8+ T cells are present in liver metastases of CRC patients, but their tumor-specific cytotoxic activity may be dependent on the presence of tumor antigens, MHC molecules, and immunosuppressive cells. The gene discussed is CD8A; the disease is neoplasm.